WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Embedded Palliative Care in the MICU

Not Applicable

Recruiting

Conditions: Critical Illness
End of Life
Quality of Life

Interventions: Other: Embedded Hospice and Palliative Care Practitioner (Group Effect)
Other: Embedded Hospice and Palliative Care Practitioner
Other: None (Historical)

First Posted Date: 2024-08-28

Last Posted Date: 2024-08-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2600

Registration Number: NCT06574672

Locations: 🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States

Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention

Not Applicable

Not yet recruiting

Conditions: Sickle Cell Disease

Interventions: Behavioral: Sickle Cell Collaboration for Child Development

First Posted Date: 2024-08-20

Last Posted Date: 2024-08-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT06562439

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer

Phase 2

Recruiting

Conditions: Node-positive Breast Cancer

Interventions: Radiation: Ultra-hypofractionated breast/chest wall and regional nodal radiation
Radiation: Hypofractionated radiation

First Posted Date: 2024-08-19

Last Posted Date: 2024-10-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 220

Registration Number: NCT06559540

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain

Not Applicable

Not yet recruiting

Conditions: Endometriosis
Pelvic Pain

Interventions: Behavioral: PEEPS
Behavioral: Education

First Posted Date: 2024-08-12

Last Posted Date: 2024-08-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 60

Registration Number: NCT06549985

A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Motixafortide
Drug: G-CSF

First Posted Date: 2024-08-09

Last Posted Date: 2024-11-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT06547112

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Study to Understand Novel Biomarkers in Researching Dementia

Conditions: Alzheimer Disease
Mild Cognitive Impairment
Dementia

Interventions: Other: Research blood collection
Diagnostic Test: Clinical tau PET
Diagnostic Test: Clinical amyloid test
Other: Cognitive assessments

First Posted Date: 2024-08-09

Last Posted Date: 2024-08-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1800

Registration Number: NCT06547099

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome

Phase 1

Not yet recruiting

Conditions: Vexas Syndrome
VEXAS
E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic Syndrome

Interventions: Drug: Pacritinib

First Posted Date: 2024-08-05

Last Posted Date: 2024-12-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT06538181

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Phase 1

Not yet recruiting

Conditions: Muscle-Invasive Bladder Carcinoma

Interventions: Biological: Synthetic long peptide personalized cancer vaccine
Drug: Poly ICLC
Biological: Nivolumab
Device: Signatera assay

First Posted Date: 2024-07-31

Last Posted Date: 2024-07-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT06529822

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

Phase 1

Recruiting

Conditions: Locally Advanced Cervical Carcinoma

Interventions: Radiation: Hypofractionated external beam radiation
Drug: Chemotherapy
Radiation: Image-guided brachytherapy

First Posted Date: 2024-07-31

Last Posted Date: 2024-10-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT06529809

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant

Phase 1

Not yet recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Recombinant glycosylated human interleukin-7
Drug: Melphalan
Procedure: Autologous hematopoietic cell transplant

First Posted Date: 2024-07-26

Last Posted Date: 2024-11-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT06523699

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy